Physiologically‐Based Pharmacokinetic Modeling of the PARP Inhibitor Niraparib
A physiologically‐based pharmacokinetic (PBPK) model of niraparib and its primary metabolite using a relevant virtual cancer population is reported here. A series of in vitro experiments using liver S9, microsomes, and hepatocytes with various inhibitors
Gareth J. Lewis +3 more
doaj +1 more source
Polymer Ring-Flexure-Membrane Suspended Gate FET Gas Sensor: Design, Modelling and Simulation. [PDF]
Zacharias J, Martha P, Seena V.
europepmc +1 more source
Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric Population. [PDF]
Lim A, Sharma P, Stepanov O, Reddy VP.
europepmc +1 more source
Dynamic Modelling and Simulation of Food Systems: Recent Trends and Applications. [PDF]
Egea JA, García MR, Vilas C.
europepmc +1 more source
3D modelling and simulation of the impact of wearing a mask on the dispersion of particles carrying the SARS-CoV-2 virus in a railway transport coach. [PDF]
Armand P, Tâche J.
europepmc +2 more sources
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers. [PDF]
Russo G +6 more
europepmc +1 more source
Modelling and simulation of waste tire pyrolysis process for recovery of energy and production of valuable chemicals (BTEX). [PDF]
Cao Y, Taghvaie Nakhjiri A, Sarkar S.
europepmc +1 more source
Docetaxel population pharmacokinetic modelling and simulation in Chinese cancer patients. [PDF]
Wei J, Zhang Y, Li Z, Li X, Zhao C.
europepmc +1 more source
Data-driven queueing modelling: a simulation case study of emergency department crowding. [PDF]
Wartelle A +4 more
europepmc +1 more source

